These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 3271193)

  • 1. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
    Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
    G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long term efficacy and toxicity of amiodarone in the treatment of refractory cardiac arrhythmias.
    Primeau R; Agha A; Giorgi C; Shenasa M; Nadeau R
    Can J Cardiol; 1989 Mar; 5(2):98-104. PubMed ID: 2706579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amiodarone for refractory cardiac arrhythmias: 10-year study.
    Leak D; Eydt JN
    CMAJ; 1986 Mar; 134(5):495-501. PubMed ID: 3948063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Long-term treatment with amiodarone].
    Baedeker W; Goedel-Meinen L; Schmidt G; Hofmann M; Barthel P; Blömer H
    Z Kardiol; 1991 Feb; 80(2):158-66. PubMed ID: 1711739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Risk stratification and long-term therapy with amiodarone in patients with idiopathic dilated cardiomyopathy].
    Zehender M; Faber T; Furtwängler A; Hohnloser S; Meinertz T; Just H
    Z Kardiol; 1992 Dec; 81(12):704-9. PubMed ID: 1492440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term results of amiodarone therapy.
    Herre JM; Sauve MJ; Scheinman MM
    Clin Cardiol; 1987 Jul; 10(7 Suppl 1):I21-5. PubMed ID: 3271187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Amiodarone and propafenone: evaluation using serial Holter recordings in patients with ventricular arrhythmia].
    Ventosa A; Adragão P; Bonhorst D; Seabra-Gomes R
    Rev Port Cardiol; 1990 Jan; 9(1):33-9. PubMed ID: 1691653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose amiodarone in severe chronic heart failure.
    Biswas A; Dey SK; Banerjee AK; Roy S; Biswas PK; Chowdhury GK; Khan AK; Mitra KK; Chatterjee SS; Maity AK
    Indian Heart J; 1996; 48(4):361-4. PubMed ID: 8908821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
    Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F
    Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Amiodarone therapy in childhood: efficacy and side effects].
    Vignati G; Danzi GB; Austoni P; Fancini P; Mascarello M; Figini A
    G Ital Cardiol; 1985 Aug; 15(8):786-94. PubMed ID: 2935440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of long-term treatment with amiodarone for life-threatening arrhythmias.
    Burckhardt D
    J Cardiovasc Pharmacol; 1992; 20 Suppl 2():S59-62. PubMed ID: 1279310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [What is the latest in anti-arrhythmia therapy?].
    Gloor HO
    Schweiz Med Wochenschr; 1991 Nov; 121(47):1711-4. PubMed ID: 1720259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F; Rolli A; Carboni A; Finardi A; Aurier E; Favaro L; Contini S; Gherli T; Caponi D; Maranga SS; Lepera G; Bartoletti A
    G Ital Cardiol; 1999 Oct; 29(10):1142-56. PubMed ID: 10546124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.